Diametric Capital’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Buy |
38,858
+14,514
| +60% | +$203K | 0.29% | 98 |
|
|
2025
Q1 | $381K | Buy |
24,344
+3,974
| +20% | +$62.2K | 0.45% | 77 |
|
|
2024
Q4 | $284K | Sell |
20,370
-12,537
| -38% | -$175K | 0.19% | 168 |
|
|
2024
Q3 | $306K | Buy |
32,907
+20,481
| +165% | +$190K | 0.15% | 208 |
|
|
2024
Q2 | $116K | Buy |
+12,426
| New | +$116K | 0.06% | 302 |
|
|
2023
Q2 | – | Sell |
-14,644
| Closed | -$161K | – | 353 |
|
|
2023
Q1 | $161K | Buy |
+14,644
| New | +$161K | 0.08% | 240 |
|